# OnCo record golseek-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/golseek-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "golseek-1", "NCT06356129" ;
  schema:name "GOLSEEK-1"@en ;
  schema:description "GOLSEEK-1 is a recruiting phase 3 that tests whether adding golcadomide, an oral cereblon-modulating degrader, to R-CHOP raises cure rates in untreated high-risk large B-cell lymphoma. It builds on high complete response rates in phase 1b, and readout is expected in 2027 to 2028."@en ;
  schema:url <https://onco.cc/trials/golseek-1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06356129> ;
  onco:status "active" ;
  onco:phase "3" ;
  schema:startDate "2024-06-19" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:drugs <https://onco.cc/drugs/golcadomide/> .